Artikel ; Online: Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance.
2021 Band 46, Heft 1, Seite(n) 73–82
Abstract: Oxidative stress role on metformin process of dacarbazine (DTIC) inducing resistance of B16F10 melanoma murine cells are investigated. To induce resistance to DTIC, murine melanoma cells were exposed to increasing concentrations of dacarabazine (DTIC-res ...
| Abstract | Oxidative stress role on metformin process of dacarbazine (DTIC) inducing resistance of B16F10 melanoma murine cells are investigated. To induce resistance to DTIC, murine melanoma cells were exposed to increasing concentrations of dacarabazine (DTIC-res group). Metformin was administered before and during the induction of resistance to DTIC (MET-DTIC). The oxidative stress parameters of the DTIC-res group showed increased levels of malondialdehyde (MDA), thiol, and reduced nuclear p53, 8-hydroxy-2'-deoxyguanosine (8-OH-DG), nuclear factor kappa B (NF-ĸB), and Nrf2. In presence of metformin in the resistant induction process to DTIC, (MET-DTIC) cells had increased antioxidant thiols, MDA, nuclear p53, 8-OH-DG, Nrf2, and reducing NF-ĸB, weakening the DTIC-resistant phenotype. The exclusive administration of metformin (MET group) also induced the cellular resistance to DTIC. The MET group presented high levels of total thiols, MDA, and reduced percentage of nuclear p53. It also presented reduced nuclear 8-OH-DG, NF-ĸB, and Nrf2 when compared with the control. Oxidative stress and the studied biomarkers seem to be part of the alterations evidenced in DTIC-resistant B16F10 cells. In addition, metformin administration is able to play a dual role according to the experimental protocol, preventing or inducing a DTIC-resistant phenotype. These findings should help future research with the aim of investigating DTIC resistance in melanoma. |
|||||
|---|---|---|---|---|---|---|
| Mesh-Begriff(e) | 8-Hydroxy-2'-Deoxyguanosine/metabolism ; Animals ; Antineoplastic Agents, Alkylating/pharmacology ; Antioxidants/pharmacology ; Cell Line, Tumor ; Dacarbazine/pharmacology ; Drug Resistance, Neoplasm/drug effects ; Malondialdehyde/metabolism ; Melanoma, Experimental/drug therapy ; Melanoma, Experimental/metabolism ; Melanoma, Experimental/pathology ; Metformin/pharmacology ; Mice ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Oxidative Stress/drug effects ; Skin Neoplasms/drug therapy ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology ; Tumor Suppressor Protein p53/metabolism | |||||
| Chemische Substanzen | Antineoplastic Agents, Alkylating ; Antioxidants ; NF-E2-Related Factor 2 ; NF-kappa B ; Nfe2l2 protein, mouse ; TP53 protein, human ; Tumor Suppressor Protein p53 ; Malondialdehyde (4Y8F71G49Q) ; Dacarbazine (7GR28W0FJI) ; 8-Hydroxy-2'-Deoxyguanosine (88847-89-6) ; Metformin (9100L32L2N) | |||||
| Sprache | Englisch | |||||
| Erscheinungsdatum | 2021-09-21 | |||||
| Erscheinungsland | England | |||||
| Dokumenttyp | Journal Article | |||||
| ZDB-ID | 1143453-3 | |||||
| ISSN | 1095-8355 ; 1065-6995 | |||||
| ISSN (online) | 1095-8355 | |||||
| ISSN | 1065-6995 | |||||
| DOI | 10.1002/cbin.11700 | |||||
| Signatur |
|
|||||
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 1451: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.